• to decreased the risk of major cardiovascular (heart and blood vessel) complications in adults with kind two diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss pill in Could but remains hoping to get a slice of the industry with MariTide, a month-to-month injection that's taken few